Compare CMRE & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMRE | HTFL |
|---|---|---|
| Founded | 1974 | 2007 |
| Country | Monaco | United States |
| Employees | 1880 | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | N/A | N/A |
| Metric | CMRE | HTFL |
|---|---|---|
| Price | $16.65 | $22.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $12.00 | ★ $39.20 |
| AVG Volume (30 Days) | 423.5K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $40.42 |
| Revenue Next Year | N/A | $22.73 |
| P/E Ratio | $5.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.63 | $20.13 |
| 52 Week High | $17.91 | $41.22 |
| Indicator | CMRE | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 44.23 |
| Support Level | $16.33 | $20.13 |
| Resistance Level | $16.67 | $25.05 |
| Average True Range (ATR) | 0.54 | 1.39 |
| MACD | -0.12 | 0.06 |
| Stochastic Oscillator | 36.82 | 44.61 |
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and others. The company provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.